Researchers Expect GSK’s Alli Lifestyle Marketing To Catch On With Other Firms
This article was originally published in The Pink Sheet Daily
Executive Summary
Researchers say marketing could prompt other firms to “play down the effectiveness of their products” and promote them as additions to healthy lifestyles, not as complete solutions to consumers’ health needs.
You may also be interested in...
GlaxoSmithKline To Market Merck’s Mevacor OTC In U.S.
An FDA joint advisory committee meets Dec. 13 to evaluate Merck data supporting the Rx-to-OTC switch.
OTC Prices Make PPI-Aspirin Therapy For CVD Cost-Effective – Study
Using proton pump inhibitors to prevent GI bleeding from low-dose aspirin therapy for cardiovascular health is cost-effective only at OTC prices, according to researchers